Related Experiment Video
Updated: Jun 11, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Model of cryptogenic infantile spasms after prenatal corticosteroid priming
Libor Velísek1, Tamar Chachua, Mi-Sun Yum
1The Saul R Korey Department of Neurology, Albert Einstein College of Medicine, Bronx, New York 10461, USA. libor.velisek@einstein.yu.edu
Insights
A new rat model mimics infantile spasms (IS), a severe childhood epilepsy. This model, induced by NMDA and betamethasone, shows promise for developing safer, novel IS therapies.
Area of Science:
- Neuroscience
- Developmental Biology
- Pediatric Neurology
Background:
- Infantile spasms (IS) is a severe epilepsy syndrome in infants (3-12 months old).
- Current hormonal therapies like ACTH and corticosteroids have significant side effects.
- A validated animal model is crucial for researching novel IS treatments.
Purpose of the Study:
- To develop and validate an animal model for infantile spasms.
- To investigate the neurobiological underpinnings of IS using this model.
Main Methods:
- Infant rats were prenatally exposed to betamethasone.
- Spastic seizures were triggered using N-methyl-d-aspartate (NMDA).
- Electroencephalography (EEG), autoradiographic metabolic mapping, and c-fos expression were used to analyze seizure activity and neuronal involvement.
Main Results:
- The model exhibited spasms similar to human IS, including motor flexion and EEG electrodecrement.
- The spasms responded to ACTH, a known IS treatment.
- Neuronal excitation primarily involved hypothalamic structures like the arcuate nucleus, with minimal hippocampal involvement.
Conclusions:
- This NMDA-induced seizure model in betamethasone-exposed infant rats effectively mimics key features of human infantile spasms.
- The model's reliance on hypothalamic structures offers new insights into IS pathophysiology.
- This validated model is suitable for preclinical research into novel infantile spasms therapies.
Abstract:
Infantile spasms (IS) is a devastating epilepsy syndrome of childhood. IS occurs in 3-12-month-old infants and is characterized by spasms, interictal electroencephalography (EEG) hypsarrhythmia, and profound mental retardation. Hormonal therapy [adrenocorticotropic hormone (ACTH), corticosteroids] is frequently used, but its efficacy is tainted by severe side effects. For research of novel therapies, a validated animal model of IS is required. We propose the model of spastic seizures triggered by N-methyl-d-aspartate (NMDA) in infant rats prenatally exposed to betamethasone. The spasms have remarkable similarity to human IS, including motor flexion spasms, ictal EEG electrodecrement, and responsiveness to ACTH. Interestingly, the spasms do not involve the hippocampus. Autoradiographic metabolic mapping as well as tagging of the areas of neuronal excitation with c-fos indicates a strong involvement of hypothalamic structures such as the arcuate nucleus, which has significant bilateral connections with other hypothalamic nuclei as well as with the brainstem.
More Related Videos
Related Concept Videos
Tetanus
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

